Showing results (1221-1230 of 1,398) with videos related to

Sort By:
Pageof 140
Journal of Interventional Medicine|November 22, 2021
Application of retrievable Solitaire AB stents in the endovascular treatment of acute ischemic strokeTeng-Fei Zhou, Liang-Fu Zhu, Tian-Xiao Li, et al.
The Journal of International Medical Research|January 12, 2023
The inflammatory cytokine profiles and ocular biometric characteristics of primary angle-closure glaucomaHong-Bo Zeng, Jun-Di Jiang, Rong Li, et al.
Medical Oncology (Northwood, London, England)|November 17, 2010
Overexpression of SGLT1 and EGFR in colorectal cancer showing a correlation with the prognosisGui Fang Guo, Yu Chen Cai, Bei Zhang, et al.
ACS Nano|October 19, 2020
Solution-Based Synthesis of Layered Two-Dimensional Oxides as Broadband EmittersFei Zhou, Shancheng Yan, Fuyi Yang, et al.
Scientific Reports|November 25, 2015
Stimulation of autophagy promotes functional recovery in diabetic rats with spinal cord injuryKai-liang Zhou, Yi-fei Zhou, Kai Wu, et al.
Light, Science & Applications|June 22, 2026
10<sup>-21</sup>-Level optical frequency dissemination over 2067 km of noise-loaded field-deployed fiber networkFa-Xi Chen, Li-Bo Li, Jiu-Peng Chen, et al.
Therapeutic Advances in Medical Oncology|November 24, 2022
Immune checkpoint inhibitors plus chemotherapy in patients with locally advanced or metastatic pulmonary sarcomatoid carcinoma: a multicentric real-world studyFei Zhou, Haoyue Guo, Xiaolong Zhou, et al.
Nature Communications|April 11, 2020
Metal chloride perovskite thin film based interfacial layer for shielding lithium metal from liquid electrolyteYi-Chen Yin, Qian Wang, Jing-Tian Yang, et al.
Thoracic Cancer|February 23, 2019
Larger tumors are associated with inferior progression-free survival of first-line EGFR-tyrosine kinase inhibitors and a lower abundance of EGFR mutation in patients with advanced non-small cell lung cancerYingying Pan, Guanghui Gao, Xiaoxia Chen, et al.
Translational Lung Cancer Research|March 10, 2023
Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer harboring <i>BRAF</i> mutationsHaowei Wang, Lei Cheng, Chao Zhao, et al.
Pageof 140